Hong Kong Stock Mid-Day Review: Hang Seng Index Rises 1.88%, ChiNext Index Rises 2.35%! Tencent Rises 3% to Create Near-4-Year High, Tencent Music Rises 15%, Hongteng Precision Rises 8%, Alibaba Rises 4%
August 13, 2025 news, Hong Kong stocks three major indices high open and rise. As of mid-day closing, the Hang Seng Index rose 1.88%, to 25439.91 points, the Hong Kong Tech Index rose 2.35%, and the state-owned enterprise index rose 1.86%. On the market, sci-tech stocks are all up, with Bilibili rising over 5%, Alibaba rising over 4%, Meituan, Tencent, and Kuaishou rising over 3%; the entertainment industry is strong, with Tencent Music rising over 15%.
The entertainment industry is strong, with Tencent Music rising over 15%. Tencent Music-SW (01698.HK) announced its unaudited financial performance for the second quarter of 2025, with total revenue reaching RMB 84.4 billion (USD 11.8 billion), a year-on-year increase of 17.9%. The company's equity holders' share of net profit was RMB 24.1 billion (USD 3.36 billion), an increase of 43.2%.
Goldman Sachs released a research report, stating that due to Tencent Music-SW's (01698) non-subscription business exceeding expectations, it has raised its 25/26-year non-IFRS net profit forecast by 6.8%/13.0% to RMB 94.6/112.1 billion. The current Hong Kong stock market corresponds to a 26.8/22.3 times non-IFRS P/E ratio, while the US stock market corresponds to a 26.7/22.2 times non-IFRS P/E ratio.
The Apple concept continued to rise, with Hongteng Precision rising over 8%. US President Trump announced plans to impose a 100% tariff on semiconductor imports, but promised that companies that make large-scale investments in the US would be exempt. Zhongyuan International believes that this exemption policy will have a positive impact on the following fields: 1) smartphone/iPad/TWS-related enterprises, as Apple/Samsung's exemption will alleviate concerns about the 232 tariff; and 2) server/AI server enterprises, as server assembly is located in Mexico (according to USMCA agreement) and Huawei (NVDA.US) has promised to invest USD 5 billion in AI infrastructure investment in the US, which will maintain tariff exemptions.
Biotechnology stocks rose sharply, with Beihai Kangcheng rising over 34%. Beihai Kangcheng announced that it will issue 74.97 million new shares to Baoyuan Pharmaceutical (301015.SZ) at a price of HK$1.34 per share, a 19.76% discount compared to the previous closing price. The total consideration is approximately HK$98.66 million, which will be used for product development and marketing activities, debt repayment, and daily operations.
China's securities stocks rose widely, with Guoliang Minsheng rising over 7%. East Sea Securities pointed out that the multi-layered capital market system is gradually being built and improved, aimed at enhancing the investment value of listed companies and investor returns. In the future, further relaxation of financing regulations and interoperability may be gradually introduced, which will enhance the attractiveness of the capital market.
Source: Sina Net